Blood test supports use of potential new treatment for patients with stomach cancer

Testing cancers for ‘addiction’ to a gene that boosts cell growth can pick out patients who may respond to a targeted drug under development, a major new study reports. By measuring the number of copies of just one gene from cancer DNA circulating in the bloodstream, scientists were able to identify the patients with stomach cancer who were most likely to respond to treatment.